Journal of Natural Medicines

, Volume 67, Issue 4, pp 719–724 | Cite as

Improvement in blood fluidity by Kaempferia parviflora rhizome

  • Kazuya Murata
  • Takahiro Deguchi
  • Takanori Fujita
  • Hideaki MatsudaEmail author
Original Paper


Improvement in blood fluidity leads to the prevention of various lifestyle-related diseases. A raw material for improving blood fluidity has been long desired in the research area of functional and supplemental foods. We successfully showed an improvement in blood fluidity by the Zingiberaceae plant, Kaempferia parviflora. The rhizome of the plant reduced the blood passage time through a micro slit using a disseminated intravascular coagulation model. The mechanism was attributed to the activation of fibrinolysis, as demonstrated by elongation of the euglobulin lysis time and an in-vitro fibrinolysis assay. The active principles were determined to be methoxyflavones. The results show that the rhizome of K. parviflora is a promising candidate preventive agent for treating lifestyle-related diseases.


Kaempferia parviflora Fibrinolysis Euglobulin lysis time Disseminated intravascular coagulation Methoxyflavones Fibrinolytic area assay 



This study was financially supported by the “Antiaging Center Project” for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, 2008–2012.


  1. 1.
    Rujjanawate C, Kanjanapothi D, Amornlerdpison D, Pojanagaroon S (2005) Anti-gastric ulcer effect of Kaempferia parviflora. J Ethnopharm 102:120–122CrossRefGoogle Scholar
  2. 2.
    Chaturapanich G, Chiyakul S, Verawatnapakul V, Pholpramool C (2008) Effects of Kaempferia parviflora extracts on reproductive parameters and spermatic blood flow in male rats. Reproduction 136:515–522PubMedCrossRefGoogle Scholar
  3. 3.
    Nakao K, Murata K, Deguchi T, Itoh K, Fujita T, Higashino M, Yoshioka Y, Matsumura S, Tanaka R, Shinada T, Ohfune Y, Matsuda H (2011) Xanthine oxidase inhibitory activities and crystal structures of methoxyflavones from Kaempferia parviflora rhizome. Biol Pharm Bull 34:1143–1146PubMedCrossRefGoogle Scholar
  4. 4.
    Guh JH, Ko FN, Jong TT, Teng CM (1995) Antiplatelet effect of gingerol isolated from Zingiber officinale. J Pharm Pharmacol 47:329–332PubMedCrossRefGoogle Scholar
  5. 5.
    Hibino T, Yuzurihara M, Terawaki K, Kanno H, Kase Y, Takeda A (2008) Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood. J Pharm Sci 108:89–94CrossRefGoogle Scholar
  6. 6.
    Schoendorf TH, Rosenberg M, Beller FK (1971) Endotoxin-induced disseminated intravascular coagulation in nonpregnant rats. Am J Pathol 65:51–58PubMedGoogle Scholar
  7. 7.
    Kaulla KN, Schultz RL (1958) Methods for the evaluation of human fibrinolysis; studies with two combined technics. Am J Clin Pathol 29:104–112Google Scholar
  8. 8.
    Norén I, Ramström G, Wallén P (1975) Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma. Haemostasis 4:110–124PubMedGoogle Scholar

Copyright information

© The Japanese Society of Pharmacognosy and Springer Japan 2012

Authors and Affiliations

  • Kazuya Murata
    • 1
  • Takahiro Deguchi
    • 1
  • Takanori Fujita
    • 2
  • Hideaki Matsuda
    • 1
    Email author
  1. 1.Faculty of PharmacyKinki UniversityHigashiosakaJapan
  2. 2.Japan Tablet CorporationUjiJapan

Personalised recommendations